Reflections on the TransMet Trial

Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial

10.1016/s0140-6736(24)01595-2 · 2024

Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery

10.1634/theoncologist.2009-0233 · 2010

Risk of morbidity and mortality following hepatopancreatic surgery

2012

Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series

10.1111/j.1463-1318.2010.02539.x · 2012

Debulking surgery for colorectal liver metastases: foolish or chance?

10.1016/j.suronc.2020.02.008 · 2020

Survival outcomes after portal vein embolization and liver resection compared with liver transplant for patients with extensive colorectal cancer liver metastases

10.1001/jamasurg.2021.0267 · 2021

Safety and feasibility of chemotherapy followed by liver transplantation for patients with definitely unresectable colorectal liver metastases: insights from the TransMet randomised clinical trial

10.1016/j.eclinm.2024.102608 · 2024

Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines